|
|
Blood, 1 January 2006, Vol. 107, No. 1, pp. 349-354.
Prepublished online as a Blood First Edition Paper on September 13, 2005; DOI 10.1182/blood-2005-06-2477.
Previous Article | Next Article 
Submitted June 23, 2005
Accepted August 26, 2005
Microcytic anemia and hepatic iron overload in a child with compound heterozygous mutations in DMT1
Achille Iolascon*, Maria d'Apolito, Veronica Servedio, Flora Cimmino, Antonio Piga, and Clara Camaschella
Genetica Medica, Dip. di Biochimica e Biotecnologie Mediche, Universita Federico II and CEINGE Advanced Biotechnologies, Napoli, Italy
Laboratorio di Medicina Molecolare, Dip. Di Scienze Mediche e del Lavoro, Universita degli Studi Foggia, Foggia, Foggia, Italy
Dipartimento di Pediatria, Universita di Torino, Torino, Italy
Universita Vita-Salute, Istituto Scientifico San Raffaele, Milano, Italy
* Corresponding author; email: iolascon{at}dbbm.unina.it.
Divalent metal transporter 1 (DMT1) mediates apical iron uptake in duodenal enterocytes and iron transfer from the transferrin receptor endosomal cycle into the cytosol in erythroid cells. Both mk mice and Belgrade rats, which carry an identical DMT1 mutation, exhibit severe microcytic anemia at birth, defective intestinal iron absorption and erythroid iron utilization. We report the hematological phenotype of a child, compound heterozygote for two DMT1 mutations, who was affected by severe anemia since birth and showed hepatic iron overload. The novel mutations were a 3 bp deletion in intron 4 (c.310 - 3_5del CTT) resulting in a splicing abnormality and a C >T transition at nucleotide 1246(p. R416C). A striking reduction of DMT1 protein in peripheral blood mononuclear cells was demonstrated by western blot. The proband required blood transfusions until erythropoietin treatment allowed transfusion-independence with haemoglobin levels between 7.5-9.5 g/dL. Hematological data of this patient at birth and in the first years of life strengthen the essential role of DMT1 in erythropoiesis. The early onset of iron overload indicates that, as in animal models, DMT1 is dispensable for liver iron uptake, whereas its deficiency in the gut is likely bypassed by upregulation of other pathways of iron absorption.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Iolascon, L. De Falco, and C. Beaumont
Molecular basis of inherited microcytic anemia due to defects in iron acquisition or heme synthesis
Haematologica,
March 1, 2009;
94(3):
395 - 408.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. J. Foot, H. E. Dalton, L. M. Shearwin-Whyatt, L. Dorstyn, S.-S. Tan, B. Yang, and S. Kumar
Regulation of the divalent metal ion transporter DMT1 and iron homeostasis by a ubiquitin-dependent mechanism involving Ndfips and WWP2
Blood,
November 15, 2008;
112(10):
4268 - 4275.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Melis, M. Cau, R. Congiu, G. Sole, S. Barella, A. Cao, M. Westerman, M. Cazzola, and R. Galanello
A mutation in the TMPRSS6 gene, encoding a transmembrane serine protease that suppresses hepcidin production, in familial iron deficiency anemia refractory to oral iron
Haematologica,
October 1, 2008;
93(10):
1473 - 1479.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. L. Levine and D. G. Gilliland
Myeloproliferative disorders
Blood,
September 15, 2008;
112(6):
2190 - 2198.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Guillem, S. Lawson, C. Kannengiesser, M. Westerman, C. Beaumont, and B. Grandchamp
Two nonsense mutations in the TMPRSS6 gene in a patient with microcytic anemia and iron deficiency
Blood,
September 1, 2008;
112(5):
2089 - 2091.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. C. Andrews
Forging a field: the golden age of iron biology
Blood,
July 15, 2008;
112(2):
219 - 230.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Camaschella, A. Campanella, L. De Falco, L. Boschetto, R. Merlini, L. Silvestri, S. Levi, and A. Iolascon
The human counterpart of zebrafish shiraz shows sideroblastic-like microcytic anemia and iron overload
Blood,
August 15, 2007;
110(4):
1353 - 1358.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Thompson, R. M. Molina, J. D. Brain, and M. Wessling-Resnick
Belgrade Rats Display Liver Iron Loading
J. Nutr.,
December 1, 2006;
136(12):
3010 - 3014.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Lam-Yuk-Tseung, V. Picard, and P. Gros
Identification of a Tyrosine-based Motif (YGSI) in the Amino Terminus of Nramp1 (Slc11a1) That Is Important for Lysosomal Targeting
J. Biol. Chem.,
October 20, 2006;
281(42):
31677 - 31688.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Pospisilova, M. P. Mims, E. Nemeth, T. Ganz, and J. T. Prchal
DMT1 mutation: response of anemia to darbepoetin administration and implications for iron homeostasis.
Blood,
July 1, 2006;
108(1):
404 - 405.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Beaumont, J. Delaunay, G. Hetet, B. Grandchamp, M. de Montalembert, and G. Tchernia
Two new human DMT1 gene mutations in a patient with microcytic anemia, low ferritinemia, and liver iron overload
Blood,
May 15, 2006;
107(10):
4168 - 4170.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Donovan, C. N. Roy, and N. C. Andrews
The Ins and Outs of Iron Homeostasis
Physiology,
April 1, 2006;
21(2):
115 - 123.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|